GGrantIndex
Sort

51,593 grants matching hepatitis

HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)

$3,241,549
Stephen A Spector · University Of California, San Diego · UM1 · FY2020 · AI

Epidemiology and Natural History of Cancer-Associated Viruses

$3,239,380
Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit

$3,238,675
Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2024 · AI

Developmental Core

$3,237,572
Paul A. Goepfert · University Of Alabama At Birmingham · P30 · FY2016 · AI

Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit

$3,235,110
Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2023 · AI

UCSD Collaborative Clinical Trials Unit

$3,234,709
Constance Ann Benson · University Of California, San Diego · UM1 · FY2023 · AI

Emory-CDC CTU

$3,234,078
Colleen F Kelley · Emory University · UM1 · FY2025 · AI

Women's Interagency HIV Study (WIHS) IV, Chicago Consortium

$3,229,376
Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2012 · AI

Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU

$3,226,409
Daniel R Kuritzkes · Massachusetts General Hospital · UM1 · FY2012 · AI

Solid Organ Transplantation in HIV: Multi-Site Study

$3,224,231
Peter G Stock · University Of California, San Francisco · U01 · FY2006 · AI

CWRU Center for Excellence on the Impact of Substance Use on HIV

$3,215,717
Alan David Levine · Case Western Reserve University · P30 · FY2023 · DA

CWRU Center for Excellence on the Impact of Substance Use on HIV

$3,215,717
Alan David Levine · Case Western Reserve University · P30 · FY2024 · DA

CWRU Center for Excellence on the Impact of Substance Use on HIV

$3,215,234
Alan David Levine · Case Western Reserve University · P30 · FY2025 · DA

Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)

$3,214,086
Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2025 · AI

CWRU Center for Excellence on the Impact of Substance Use on HIV

$3,213,141
Alan David Levine · Case Western Reserve University · P30 · FY2022 · DA

UZCHS CTU

$3,210,348
Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2017 · AI

Stroke with Transfusions Changing to Hydroxyurea

$3,207,047
Russell E Ware · St. Jude Children'S Research Hospital · U01 · FY2006 · HL

Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans

$3,206,850
Maria Virginia Pascual · Baylor Research Institute · U19 · FY2014 · AI

Women's Interagency HIV Study (WIHS) IV

$3,198,087
Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny) · U01 · FY2012 · AI

CWRU Center for Excellence on the Impact of Substance Use on HIV

$3,195,848
Alan David Levine · Case Western Reserve University · P30 · FY2021 · DA

OPERATION AND MAINTENANCE OF A CHIMPANZEE FACILITY

$3,190,176
Brian Corning · Charles River Laboratories Intntl, Inc. · N01 · FY2011 · RR

Connecticut Emerging Infections Program

$3,189,124
James L Hadler · Connecticut State Dept Of Public Health · U01 · FY2008 · CI

Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments

$3,187,485
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL

Role of G protein-coupled receptors in regulating glucose and energy homeostasis

$3,184,111
Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Intestinal proteases in alcohol-associated liver disease

$3,182,397
Bernd G. Schnabl · University Of California, San Diego · R01 · FY2025 · AA